FDA Approves First-Of-A-Kind Test For Cancer Gene ProfilingU.S. regulators have approved a first-of-a-kind test that looks for mutations in hundreds of cancer genes at once, giving a more complete picture of what's driving a patient's tumor and aiding efforts to match treatments to those flaws.
Study: PSA Rise Not Good Prostate Cancer PredictorA rising PSA level isn't such a good predictor of prostate cancer after all and can lead to many unnecessary biopsies, says a large new study.

More From CBS Dallas / Fort Worth

Drip Pan: CBS Local App
Drip Pan: Weather App
Drip Pan: Only CBS

Watch & Listen LIVE